Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hospital-Acquired Pneumonia (HAP) Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hospital-Acquired Pneumonia (HAP) Drugsmarket, defines the market attractiveness level of Hospital-Acquired Pneumonia (HAP) Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hospital-Acquired Pneumonia (HAP) Drugs industry, describes the types of Hospital-Acquired Pneumonia (HAP) Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hospital-Acquired Pneumonia (HAP) Drugs market and the development prospects and opportunities of Hospital-Acquired Pneumonia (HAP) Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hospital-Acquired Pneumonia (HAP) Drugs market in Chapter 13.
By Player:
Mylan
Pfizer
Theravance Biopharma
AstraZeneca
Merck
Shinogi
The Medicines Company
Novartis
Sun Pharmaceutical Industries
Teva Pharmaceutical Industries
By Type:
Antibacterial
Antiviral
Antifungal
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hospital-Acquired Pneumonia (HAP) Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hospital-Acquired Pneumonia (HAP) Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hospital-Acquired Pneumonia (HAP) Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hospital-Acquired Pneumonia (HAP) Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hospital-Acquired Pneumonia (HAP) Drugs Market Analysis and Outlook to 2022
-
7.1 Global Hospital-Acquired Pneumonia (HAP) Drugs Consumption (2017-2022)
-
7.2 United States Hospital-Acquired Pneumonia (HAP) Drugs Consumption (2017-2022)
-
7.3 Europe Hospital-Acquired Pneumonia (HAP) Drugs Consumption (2017-2022)
-
7.4 China Hospital-Acquired Pneumonia (HAP) Drugs Consumption (2017-2022)
-
7.5 Japan Hospital-Acquired Pneumonia (HAP) Drugs Consumption (2017-2022)
-
7.6 India Hospital-Acquired Pneumonia (HAP) Drugs Consumption (2017-2022)
-
7.7 South Korea Hospital-Acquired Pneumonia (HAP) Drugs Consumption (2017-2022)
8 Region and Country-wise Hospital-Acquired Pneumonia (HAP) Drugs Market Analysis and Outlook to 2028
-
8.1 Global Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast (2022-2028)
-
8.2 United States Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast (2022-2028)
-
8.4 China Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast (2022-2028)
-
8.6 India Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast (2022-2028)
9 Global Hospital-Acquired Pneumonia (HAP) Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Hospital-Acquired Pneumonia (HAP) Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antibacterial Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antiviral Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Antifungal Consumption and Growth Rate (2017-2022)
-
9.2 Global Hospital-Acquired Pneumonia (HAP) Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Hospital-Acquired Pneumonia (HAP) Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antibacterial Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Antiviral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Antifungal Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Hospital-Acquired Pneumonia (HAP) Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hospital-Acquired Pneumonia (HAP) Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hospital-Acquired Pneumonia (HAP) Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hospital-Acquired Pneumonia (HAP) Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hospital-Acquired Pneumonia (HAP) Drugs Market Competitive Analysis
-
14.1 Mylan
-
14.1.1 Mylan Company Details
-
14.1.2 Mylan Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Mylan Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
14.3 Theravance Biopharma
-
14.3.1 Theravance Biopharma Company Details
-
14.3.2 Theravance Biopharma Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Theravance Biopharma Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
14.4 AstraZeneca
-
14.4.1 AstraZeneca Company Details
-
14.4.2 AstraZeneca Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AstraZeneca Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
14.5 Merck
-
14.5.1 Merck Company Details
-
14.5.2 Merck Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merck Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
14.6 Shinogi
-
14.6.1 Shinogi Company Details
-
14.6.2 Shinogi Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Shinogi Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
14.7 The Medicines Company
-
14.7.1 The Medicines Company Company Details
-
14.7.2 The Medicines Company Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 The Medicines Company Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
14.8 Novartis
-
14.8.1 Novartis Company Details
-
14.8.2 Novartis Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novartis Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
14.9 Sun Pharmaceutical Industries
-
14.9.1 Sun Pharmaceutical Industries Company Details
-
14.9.2 Sun Pharmaceutical Industries Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Sun Pharmaceutical Industries Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
14.10 Teva Pharmaceutical Industries
-
14.10.1 Teva Pharmaceutical Industries Company Details
-
14.10.2 Teva Pharmaceutical Industries Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Teva Pharmaceutical Industries Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hospital-Acquired Pneumonia (HAP) Drugs
-
Figure Hospital-Acquired Pneumonia (HAP) Drugs Picture
-
Table Global Hospital-Acquired Pneumonia (HAP) Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hospital-Acquired Pneumonia (HAP) Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hospital-Acquired Pneumonia (HAP) Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hospital-Acquired Pneumonia (HAP) Drugs Consumption by Country (2017-2022)
-
Figure United States Hospital-Acquired Pneumonia (HAP) Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Hospital-Acquired Pneumonia (HAP) Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Hospital-Acquired Pneumonia (HAP) Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Hospital-Acquired Pneumonia (HAP) Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Hospital-Acquired Pneumonia (HAP) Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hospital-Acquired Pneumonia (HAP) Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hospital-Acquired Pneumonia (HAP) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibacterial Consumption and Growth Rate (2017-2022)
-
Figure Global Antiviral Consumption and Growth Rate (2017-2022)
-
Figure Global Antifungal Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Antibacterial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antiviral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antifungal Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hospital-Acquired Pneumonia (HAP) Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hospital-Acquired Pneumonia (HAP) Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
Table Theravance Biopharma (Foundation Year, Company Profile and etc.)
-
Table Theravance Biopharma Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Theravance Biopharma Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
Table Shinogi (Foundation Year, Company Profile and etc.)
-
Table Shinogi Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shinogi Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
Table The Medicines Company (Foundation Year, Company Profile and etc.)
-
Table The Medicines Company Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table The Medicines Company Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
Table Sun Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceutical Industries Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Industries Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Hospital-Acquired Pneumonia (HAP) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Hospital-Acquired Pneumonia (HAP) Drugs Product and Service
-
